Skip to content

Assessment of the Performance of a New Reduced Noise Mask Vent

Clinical Trial of a New Mask Vent, Designed to Reduce Noise of Mask Venting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01575210
Enrollment
31
Registered
2012-04-11
Start date
2012-06-30
Completion date
2012-10-31
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnoea (OSA)

Brief summary

As continuous positive airway pressure is the treatment of choice for OSA, a mask is vital in ensuring the effectiveness of therapy delivery. The study will evaluate the performance and usability of the new mask vent. This is done by comparing the apnea-hypopnea index (AHI) of patients, who will apply 2 different washing procedures to the new mask, at the end of the study and their baseline data obtained at the beginning of the study.The study will also assess the breathing comfort as well as obtaining subjective data on the usability of the new mask vent system.

Interventions

DEVICECPAP mask

A new vent CPAP mask system will be used in this trial.

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who are using ResMed mask * Subjects willing to provide written informed consent * Subjects who have been treated for OSA \> 6 months * Subjects who can read and comprehend English * Subjects ≥ 18 years old * Subjects who are using a ResMed S8 or S9 device

Exclusion criteria

* Patients who are pregnant * Patient on bi level treatment * Patients being treated for OSA \< 6 months * Patients who have a pre-existing lung disease/condition that would predispose them to pneumothorax (for example: COPD; lung cancer, fibrosis of the lungs; recent (\<2 years ago) case of pneumonia or lung infection; lung injury). * Patients who are deemed unsuitable by the researcher due to the following reasons: * They do not comprehend English * They are unable to provide written informed consent * They are physically unable to comply with the protocol

Design outcomes

Primary

MeasureTime frameDescription
The apnoea/hypopnoea index (AHI) will be recorded and analysed.12 weeksBreathing disruption events per hour of sleep will be measured and analysed

Secondary

MeasureTime frameDescription
The level of comfort patients experience while using the new mask vent12 weeksPatients will complete a questionnaire regarding the noise of the new vent
Patient's and bed partner's perceptions of the mask vent12 weeksPatients partners will complete a questionnaire regarding the noise of the mask vent

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026